Plasma proatrial natriuretic factor is predictive of clinical status in patients with congestive heart failure;Pro-atrial natriuretisk faktor i plasma er prediktiv for klinisk status hos hjertesviktpasienter

Tidsskrift for den Norske Laegeforening

Volumn 116, Issue 13, 1996, Pages 1562-1566

  Dickstein, Kenneth ^a   Larsen, Alf Inge ^a   Bonarjee, Vernon ^a   Thoresen, Magne ^b   Aarsland, Torbjørn ^c   Hall, Christian ^d  

^a Sentralsjukehuset i Rogaland   (Norway)

^b Medstat Research   (Norway)

^c Forskningsstiftelsen Hjertelaget   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CONGESTIVE HEART FAILURE; ECHOGRAPHY; FEMALE; HEMODYNAMICS; HUMAN; MALE; MIDDLE AGED; PROGNOSIS; SCINTISCANNING;

ADOLESCENT; ADULT; AGED; ATRIAL NATRIURETIC FACTOR; FEMALE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS;

EID: 0030594456     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Klemsdal TO, Mangschau A, Hjertesvikt i norske sykehusavdelinger. Tidsskr Nor Lægeforen 1994; 114: 2473-6.
2. DeBold A, Borenstein H, Veress A, Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 1981; 28: 89-94.
3. Thibault G, Garcia R, Gutkowska J, Bilodeau J, Lazure C, Seidah NG et al. The propeptide Asn 1-Tyr 126 is the storage form of rat atrial natriuretic factor. Biochem J 1987; 241: 265-72.
4. Edwards B, Zimmerman R, Schwab T, Heublein D, Burnett J. Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor. Circ Res 1988; 62: 191-5.
5. Raine AEG, Erne P, Bürgisser E, Müller FB, Bolli P, Burkhart F et al. Atrial natriuretic peptide and atrial pressures in patients with congestive heart failure. N Engl J Med 1986, 315: 533-7.
6. Matsubara H, Nishikawa M, Umeda Y, Taniguchi T, Iwasaka T, Kurimoto T. The role of atrial pressures in secreting atrial natriuretic polypeptides. Am Heart J 1987; 113: 1457-63.
7. Garcia R, Thibault G, Nutt R, Cantin M, Genest J. Comparative vasoactive effects of native and synthetic atrial natriuretic factor (ANF). Biochem Biophys Res Commun 1984; 119: 685-99.
8. Sundsfjord JA, Thibault G, Larochelle P, Cantin M. Identification and plasma concentrations of the N-terminal fragment of atrial natriuretic factor in man. J Clin Endocrinol Metab 1988; 66: 605-10.
9. Winters CJ, Sallman AL, Baker BJ, Meadows J, Rico DM, Vesely DL. The N-terminus and a 4,000 MW peptide from the midportion of the N-terminus of atrial natriuretic factor prohormone each circulate in humans and increase in congestive heart failure. Circulation 1989; 80: 438-49.
10. Bates ER, Shenker Y, Grekin RJ. The relationship between plasma levels of immunoreactive atrial natriuretic hormone and hemodynamic function in man. Circulation 1986; 73: 1155-61.
11. Richards AM, Cleland JFG, Tonolo G, McInryre GD, Leckie BJ, Dargie HJ. Plasma atrial natriuretic peptide in cardiac impairment. BMJ 1986; 293: 409-12.
12. Tsutamoto T, Bito K, Kinoshita M. Plasma atrial natriuretic polypeptide as an index of LV end-diastolic pressure in patients with chronic left-sided heart failure. Am Heart J 1989; 117: 599-606.
13. Mathisen P, Hall C, Simonsen S. Comparative study of atrial peptides ANF (1-98) and ANF (99-126) as diagnostic markers of atrial distension in patients with cardiac disease. Scand J Clin Lab Invest 1993; 53: 41-9.
14. Lerman A, Gibbons R, Rodeheffer R, Bailey K, McKinley L, Heublein D et al. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction. Lancet 1993; 341: 1105-9.
15. Hall C, Rouleau J, Moye L, Champlain J, Bichet D, Klein M. N-terminal proatrial natriuretic factor: an independent predictor of long-term prognosis after myocardial infarction. Circulation 1994; 89: 1934-42.
16. Yock P, Popp R. Noninvasive estimation of right ventricular systolic pressure by doppler ultrasound in patients with tricuspid regurgitation. Circulation 1984; 70: 657-62.
17. Bleken L. Pro-ANF, et nytt diagnostisk hjelperniddel ved hjertesvikt. Tidsskr Nor Lægeforen 1993; 113: 2837-8.
18. Gottlieb S, Kukin ML, Ahern D, Packer M. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol 1989; 13: 1534-9.
19. Hall C, Kjekshus J, Eneroth P, Snappin S. The plasma concentration of N-terminal proatrial natriuretic factor ANF (1-98) is related to prognosis in severe heart failure. Clin Cardiol 1994; 17: 191-5.
20. Omland T. Prognostisk verdi av neuroendokrin aktivering etter akutt hjerteinfarki. Tidsskr Nor Lægeforen 1995; 115: 2641-5.
21. Bonarjee V, Omland T, Nilsen D, Caidahl K, Sundsfjord J, Dickstein K. Plasma proatrial natriuretic factor (1-98) concentration after myocardial infarction: relation to indices of cardiac and renal function. Br Heart J 1995; 73: 511-6.
22. Yandle TG, Richards AM, Nicholls MG, Cuneo R, Espiner EA, Livesey JH. Metabolic clearance rate and plasma half-life of α-human atrial natriuretic peptide in man. Life Sciences 1986; 38: 1827-33.
23. Nelesen R, Dimsdale J, Ziegler M. Plasma atrial natriuretic peptide is unstable under most storage conditions. Circulation 1992; 86: 463-6.
24. Hall C, Aaberge L, Stokke O. In vitro stability of N-terminal proatrial natriuretic factor in unfrozen samples: an important prerequisite for its use as a biochemical parameter of atrial pressure in clinical routine. Circulation 1995; 91: 911.
25. Thibault G, Murthy KK, Gutkowska J, Seidah NG, Lazure C, Chretien M et al. NH2-terminal fragment of rat proatrial natriuretic factor in the circulation: identification, radioimmunoassay and half-life. Peptides 1988; 9: 47-53.
26. Rouleau J, Moye L, Champlain L. Activation of neurohumoral systems following acute myocardial infarction. Am J Cardiol 1991; 68 (suppl D): 80-6.
27. Fontana F, Bernardi P, Spagnolo N, Capelli M. Plasma atrial natriuretic factor in patients with acute myocardial infarction. Eur Heart J 1990; 11: 779-87.
28. Anderson J, Woodruff P, Bloom S. The effect of treatment of congestive heart failure on plasma atrial natriuretic peptide concentration: a longitudinal study. Br Heart J 1988; 59: 207-11.
29. Weston M, Cintron G, Giordano A, Vesely D. Normalization of circulating atrial peptides in cardiac transplant recipients. Am Heart J 1994; 127: 129-42.
30. Westheim A, Dickstein K, Gundersen T, Hole T, Myhre ESP, Rønnevik PK et al. Kronisk hjertesvikt. Tidsskr Nor Lægeforen 1994; 114: 1424-7.